The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial.

Jingqin MaJianjun LuoWen ZhangYongjie ZhouZihan ZhangMinjie YangZhiquan ZhuangLi MaJiaze YuXin ZhouZhiping Yan

Published in: Trials (2023)

ClinicalTrials.gov NCT03825848. Registered on January 31, 2019 TRIAL STATUS: The first patient was recruited into our study on June 19, 2019. A total of 55 patients were recruited till May 27, 2021 (27 and 28 patients assigned to shunting the left (L Group) and right (R Group) branches of the portal vein, respectively).

Keyphrases

end stage renal disease
ejection fraction
double blind
newly diagnosed
chronic kidney disease
study protocol
peritoneal dialysis
open label
phase iii
placebo controlled
phase ii
patient reported